We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.
- Authors
Rankin, E. B.; Rha, J.; Unger, T. L.; Wu, C. H.; Shutt, H. P.; Johnson, R. S.; Simon, M. C.; Keith, B.; Haase, V. H.
- Abstract
The von Hippel–Lindau tumor suppressor pVHL regulates the stability of hypoxia-inducible factors (HIF)-1 and -2, oxygen-sensitive basic helix–loop–helix transcription factors, which mediate the hypoxic induction of angiogenic growth factors such as vascular endothelial growth factor. Loss of pVHL function results in constitutive activation of HIF-1 and HIF-2 and is associated with the development of highly vascularized tumors in multiple organs. We have used a conditional gene-targeting approach to investigate the relative contributions of HIF-1 and HIF-2 to VHL-associated vascular tumorigenesis in a mouse model of liver hemangiomas. Here we demonstrate genetically that conditional inactivation of HIF-2α suppressed the development of VHL-associated liver hemangiomas and that angiogenic gene expression in hepatocytes is predominantly regulated by HIF-2 and not by HIF-1. These findings suggest that HIF-2 is the dominant HIF in the pathogenesis of VHL-associated vascular tumors and that pharmacologic targeting of HIF-2 may be an effective strategy for their treatment.Oncogene (2008) 27, 5354–5358; doi:10.1038/onc.2008.160; published online 19 May 2008
- Subjects
TUMOR suppressor genes; CARCINOGENESIS; BLOOD-vessel tumors; TRANSCRIPTION factors; TUMOR growth; ANIMAL experimentation
- Publication
Oncogene, 2008, Vol 27, Issue 40, p5354
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/onc.2008.160